|
HNRPDL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.068200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.516440E-01 |
| Normal-vs-Stage2 |
1.330840E-01 |
| Normal-vs-Stage3 |
3.223500E-03 |
| Normal-vs-Stage4 |
1.272440E-02 |
| Stage1-vs-Stage2 |
7.580400E-01 |
| Stage1-vs-Stage3 |
8.954300E-02 |
| Stage1-vs-Stage4 |
3.614300E-02 |
| Stage2-vs-Stage3 |
2.620400E-01 |
| Stage2-vs-Stage4 |
2.223600E-01 |
| Stage3-vs-Stage4 |
9.262800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.139700E-02 |
| Normal-vs-AfricanAmerican |
5.496800E-01 |
| Normal-vs-Asian |
1.066350E-02 |
| Caucasian-vs-AfricanAmerican |
6.221800E-02 |
| Caucasian-vs-Asian |
1.692830E-01 |
| AfricanAmerican-vs-Asian |
6.134400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.130300E-02 |
| Normal-vs-Female |
3.093400E-01 |
| Male-vs-Female |
1.912770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.694000E-02 |
| Normal-vs-Extreme_Weight |
7.105800E-02 |
| Normal-vs-Obese |
2.340600E-01 |
| Normal-vs-Extreme_Obese |
1.025950E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.349400E-01 |
| Normal_Weight-vs-Obese |
4.486400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.860600E-01 |
| Extreme_Weight-vs-Obese |
4.255600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.398000E-01 |
| Obese-vs-Extreme_Obese |
1.006220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.709400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.227000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.338400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.192300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.493200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.685800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.448600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.078500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.305230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.486400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.235000E-01 |
| Normal-VS-Type2 PRCC |
8.98449999953144E-08 |
| Normal-VS-KIRP CIMP |
7.261600E-02 |
| Normal-VS-Unclassified PRCC |
6.047800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.86349832734345E-11 |
| Type1 PRCC-VS-KIRP CIMP |
3.802200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.183760E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.167500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.360300E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
6.225400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76697999999531E-05 |
| Normal-vs-N1 |
4.658300E-02 |
| Normal-vs-N2 |
3.848600E-04 |
| N0-vs-N1 |
9.753500E-02 |
| N0-vs-N2 |
8.805900E-02 |
| N1-vs-N2 |
4.681400E-01 |
|
|
